Literature DB >> 25289759

Inhibitory effects of capsaicin on hepatic stellate cells and liver fibrosis.

Fu-Xiang Yu1, Yin-Yan Teng, Qian-Dong Zhu, Qi-Yu Zhang, Yin-He Tang.   

Abstract

Hepatic stellate cells (HSCs) play an important role in the process of liver fibrosis. In this study, we investigated the inhibitory effects of capsaicin on HSCs and liver fibrosis. Cultured HSCs were incubated with various concentrations of capsaicin. Cell proliferation was examined using a cell counting kit. Production of hydrogen peroxide was determined using a 2',7'-dichlorofluorescin diacetate (DCFH-DA) assay. The mRNA and protein expression of target genes was analyzed by reverse transcription PCR and Western blot analysis, respectively. Cell apoptosis was evaluated by annexin V-FITC and propidium iodide (PI) costaining followed by flow cytometric analysis. A CCl4 rat liver fibrosis model was used to assess in vivo effects of capsaicin by histological examination and measurement of liver fibrosis markers, including hydroxyproline content, serum type III collagen, and hyaluronic acid (HA) levels. Our results show that capsaicin dose-dependently inhibited cell proliferation, suppressed cell activation, and decreased hydrogen peroxide production in cultured HSCs. Capsaicin reduced the mRNA levels of tissue inhibitors of metalloproteinase 1 (TIMP-1) and transforming growth factor-β1 (TGF-β1) in HSCs. Moreover, capsaicin-induced cell apoptosis was associated with increased expression of Bax, cytochrome c (cyt c), and caspase-3, but reduced levels of Bcl-2. The animal studies further revealed that capsaicin efficiently reduced the extent of liver fibrosis, inhibited HSC proliferation, and promoted cell apoptosis. Our findings suggest that capsaicin might inhibit fibrogenesis by inhibiting the activities of HSCs.

Entities:  

Keywords:  activation; apoptose; apoptosis; capsaicin; capsaïcine; cellules hépatiques stellaires; fibrose hépatique; hepatic stellate cells; liver fibrosis

Mesh:

Substances:

Year:  2014        PMID: 25289759     DOI: 10.1139/bcb-2014-0036

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  4 in total

1.  Prolyl oligopeptidase attenuates hepatic stellate cell activation through induction of Smad7 and PPAR-γ.

Authors:  Da Zhou; Jing Wang; Ling-Nan He; Bing-Hang Li; Yong-Nian Ding; Yuan-Wen Chen; Jian-Gao Fan
Journal:  Exp Ther Med       Date:  2017-01-05       Impact factor: 2.447

2.  A Novel Matrine Derivative WM130 Inhibits Activation of Hepatic Stellate Cells and Attenuates Dimethylnitrosamine-Induced Liver Fibrosis in Rats.

Authors:  Yang Xu; Zhangxiao Peng; Weidan Ji; Xiang Li; Xuejing Lin; Liqiang Qian; Xiaoya Li; Xiaoyun Chai; Qiuye Wu; Quangen Gao; Changqing Su
Journal:  Biomed Res Int       Date:  2015-06-18       Impact factor: 3.411

3.  Skin Antiageing and Systemic Redox Effects of Supplementation with Marine Collagen Peptides and Plant-Derived Antioxidants: A Single-Blind Case-Control Clinical Study.

Authors:  Chiara De Luca; Elena V Mikhal'chik; Maxim V Suprun; Michael Papacharalambous; Arseniy I Truhanov; Liudmila G Korkina
Journal:  Oxid Med Cell Longev       Date:  2016-01-19       Impact factor: 6.543

4.  Low concentrations of bilirubin inhibit activation of hepatic stellate cells in vitro.

Authors:  Yinhe Tang; Qiyu Zhang; Yefan Zhu; Gang Chen; Fuxiang Yu
Journal:  Mol Med Rep       Date:  2017-02-14       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.